Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer C Murphy, M McGurk, J Pettigrew, A Santinelli, R Mazzucchelli, ... Clinical Cancer Research 11 (11), 4117-4127, 2005 | 282 | 2005 |
Metabolic phenotype of bladder cancer F Massari, C Ciccarese, M Santoni, R Iacovelli, R Mazzucchelli, F Piva, ... Cancer treatment reviews 45, 46-57, 2016 | 260 | 2016 |
Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications G Aurilio, A Cimadamore, R Mazzucchelli, A Lopez-Beltran, E Verri, ... Cells 9 (12), 2653, 2020 | 182 | 2020 |
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer A Lunardi, U Ala, MT Epping, L Salmena, JG Clohessy, KA Webster, ... Nature genetics 45 (7), 747-755, 2013 | 173 | 2013 |
Vascular endothelial growth factor expression and capillary architecture in high‐grade PIN and prostate cancer in untreated and androgen‐ablated patients R Mazzucchelli, R Montironi, A Santinelli, G Lucarini, A Pugnaloni, ... The Prostate 45 (1), 72-79, 2000 | 162 | 2000 |
Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate R Montironi, R Mazzucchelli, A Lopez-Beltran, L Cheng, M Scarpelli Nature Clinical Practice Urology 4 (6), 321-332, 2007 | 160 | 2007 |
Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens D Minardi, G Lucarini, R Mazzucchelli, G Milanese, D Natali, AB Galosi, ... The Journal of urology 174 (4), 1208-1212, 2005 | 133 | 2005 |
Neuroendocrine tumours of the urinary system and male genital organs: clinical significance R Mazzucchelli, D Morichetti, A Lopez‐Beltran, L Cheng, M Scarpelli, ... BJU international 103 (11), 1464-1470, 2009 | 128 | 2009 |
Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance R Montironi, R Mazzucchelli, F Algaba, A Lopez-Beltran Journal of clinical pathology 53 (9), 655-665, 2000 | 122 | 2000 |
Rare and unusual histological variants of prostatic carcinoma: clinical significance R Mazzucchelli, A Lopez‐Beltran, L Cheng, M Scarpelli, Z Kirkali, ... BJU international 102 (10), 1369-1374, 2008 | 110 | 2008 |
Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? R Montironi, R Mazzucchelli, A Lopez-Beltran, G Martignoni, L Cheng, ... European urology 54 (6), 1237-1246, 2008 | 106 | 2008 |
Current practice of Gleason grading of prostate carcinoma A Lopez-Beltran, G Mikuz, RJ Luque, R Mazzucchelli, R Montironi Virchows Archiv 448, 111-118, 2006 | 105 | 2006 |
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer A Lopez-Beltran, RJ Luque, R Mazzucchelli, M Scarpelli, R Montironi Journal of clinical pathology 55 (9), 641-647, 2002 | 105 | 2002 |
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies R Montironi, A Lopez-Beltran, R Mazzucchelli, DG Bostwick Journal of clinical pathology 56 (2), 91-95, 2003 | 104 | 2003 |
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer C Selli, R Montironi, A Bono, F Pagano, F Zattoni, A Manganelli, ... Journal of clinical pathology 55 (7), 508-513, 2002 | 101 | 2002 |
Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies:(also referred to as “atypical small acinar proliferation suspicious for but not … R Montironi, V Scattoni, R Mazzucchelli, A Lopez-Beltran, DG Bostwick, ... European urology 50 (4), 666-674, 2006 | 98 | 2006 |
Implications of the International Society of Urological Pathology modified Gleason grading system L Egevad, R Mazzucchelli, R Montironi Archives of pathology & laboratory medicine 136 (4), 426-434, 2012 | 90 | 2012 |
Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens R Montironi, R Mazzucchelli, A Santinelli, M Scarpelli, AL Beltran, ... Human pathology 36 (6), 646-654, 2005 | 89 | 2005 |
Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? R Mazzucchelli, F Barbisan, M Scarpelli, A Lopez-Beltran, ... American journal of clinical pathology 131 (2), 279-283, 2009 | 86 | 2009 |
Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises. M Santoni, M Scarpelli, R Mazzucchelli, A Lopez-Beltran, L Cheng, ... Journal of biological regulators and homeostatic agents 28 (4), 555-563, 2014 | 85 | 2014 |